tiprankstipranks
Trending News
More News >
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
US Market
Advertisement

Enanta Pharmaceuticals (ENTA) Drug Pipeline

Compare
188 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Rosuvastatin, Midazolam, Caffeine, Edp-323
Rsv Infection, Drug Drug Interaction
Phase I
Completed
A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants
Apr 01, 2025
Carbamazepine, Itraconazole, Fluconazole, Quinidine, Edp-323
Rsv Infection, Drug Drug Interaction (Ddi)
Phase I
Completed
A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.
Feb 21, 2025
Moxifloxacin, Zelicapavir (Therapeutic Dose), Zelicapavir (Supratherapeutic Dose)
Rsv Infection, Qtc Interval
Phase I
Completed
A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults
Aug 27, 2024
Edp-323 Dose Regimen 1, Edp-323 Dose Regimen 2
Rsv Infection
Phase II
Completed
A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model
Nov 27, 2023
Edp-938
Rsv Infection
Phase II
Completed
A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.
Oct 03, 2022
Edp-938
Respiratory Syncytial Virus (Rsv)
Phase II
Completed
A Study to Evaluate EDP 938 Regimens in Children With RSV
Mar 23, 2021

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Enanta Pharmaceuticals (ENTA) have in its pipeline
      ENTA is currently developing the following drugs: Rosuvastatin, Midazolam, Caffeine, Edp-323, Carbamazepine, Itraconazole, Fluconazole, Quinidine, Edp-323, Moxifloxacin, Zelicapavir (Therapeutic Dose), Zelicapavir (Supratherapeutic Dose). These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis